Evidence map›Paper›PMID 34718351›Full record

ArticlePediatric research2022

SARS-CoV-2 in infant urine and fecal samples after in utero COVID-19 exposure.

Jeffery O Boateng, Elisha M Wachman, Jacquelyn Turcinovic, Jean Devera, Mayuri Jain, Sigride Jean-Sicard, Elizabeth Woodard, Alice Cruikshank, Bharati Sinha, Ruby Bartolome and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Pediatric research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. A narrative review of COVID-19 vaccination in pregnancy and breastfeeding.Journal of perinatology : official journal of the California Perinatal Association · 2024
    Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Jeffery O BoatengDepartment of Pediatrics, Boston Medical Center, Boston, MA, USA.
Elisha M WachmanDepartment of Pediatrics, Boston Medical Center, Boston, MA, USA.
Jacquelyn TurcinovicBoston University Microbiology/NEIDL, Boston, MA, USA.
Jean DeveraBoston University School of Medicine, Boston, MA, USA.
Mayuri JainBoston University School of Public Health, Boston, MA, USA.
Sigride Jean-SicardDepartment of Pediatrics, Boston Medical Center, Boston, MA, USA.
Elizabeth WoodardDepartment of Pediatrics, Boston Medical Center, Boston, MA, USA.
Alice CruikshankDepartment of Pediatrics, Boston Medical Center, Boston, MA, USA.
Bharati SinhaDepartment of Pediatrics, Boston Medical Center, Boston, MA, USA.
Ruby BartolomeDepartment of Pediatrics, Boston Medical Center, Boston, MA, USA.
Elizabeth D BarnettDepartment of Pediatrics, Boston Medical Center, Boston, MA, USA.
Margaret G ParkerDepartment of Pediatrics, Boston Medical Center, Boston, MA, USA.
Christina YarringtonDepartment of Obstetrics and Gynecology, Boston Medical Center, Boston, MA, USA.
John H ConnorBoston University Microbiology/NEIDL, Boston, MA, USA.
Elizabeth TaglauerDepartment of Pediatrics, Boston Medical Center, Boston, MA, USA.
Vishakha SabharwalDepartment of Pediatrics, Boston Medical Center, Boston, MA, USA. vishakha.sabharwal@bmc.org.
Boston Medical Center · USBoston University · US

Funding

Project-005UL1TR001430 · NCATS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BAIR-MERRITT, MEGAN H, CENTER, DAVID M. · 2015 to 2024
$52.3M
NCATS NIH HHS UL1 TR001430
6 · The paper itself

Abstract

backgroundCoronavirus disease 2019 (COVID-19) is a pandemic that has and will continue to affect many pregnant women. Knowledge regarding the risk of vertical transmission is limited. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) real-time reverse transcriptase-polymerase chain reaction (RT-PCR) of nasopharyngeal swabs typically have been used to confirm the diagnosis among infants, but whether the virus can be detected in other biological specimens, and therefore potentially transmitted in other ways, is unknown. Positive SARS-CoV-2 RT-PCR has been reported from feces and urine from adult patients. We hypothesize that the presence of SARS-CoV-2 in infant urine and fecal samples after prenatal COVID-19 exposure is low.

methodsWe examined the presence of SARS-CoV-2 RNA using RT-PCR in urine and fecal samples among 42 infants born to SARS-CoV-2-infected mothers during different stages of pregnancy.

resultsA urine sample was collected from 39 of 42 infants and fecal samples from all 42 infants shortly after birth. Although the majority of the women had the symptomatic disease (85.6%), we were unable to detect the presence of SARS-CoV-2 virus from any infant urine or fecal samples.

conclusionsSARS-CoV-2 was not detected in infant urine or feces after maternal infection during pregnancy, providing further evidence for low rates of perinatal transmission. IMPACT: SARS-CoV-2 was not detected in the urine or feces of infants of mothers with COVID-19 during various time points in pregnancy. This study provides further evidence for low rates of perinatal transmission of SARS-CoV-2. Results help to provide guidance on perinatal care practices for infants exposed to COVID-19 in utero.

Indexed as

COVID-19Pregnancy Complications, InfectiousAdultFecesFemaleHumansInfantInfectious Disease Transmission, VerticalPregnancyRNA-Directed DNA PolymeraseRNA, ViralSARS-CoV-2RNA-Directed DNA PolymeraseRNA, Viral

Identifiers

PMID34718351
PMCPMC8556813
OpenAlexW3210134265

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.